Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K.

CMAJ. 2009 May 12;180(10):E47-57. doi: 10.1503/cmaj.090523. Epub 2009 Apr 16. No abstract available.

2.

A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Thorpe KE, Zwarenstein M, Oxman AD, Treweek S, Furberg CD, Altman DG, Tunis S, Bergel E, Harvey I, Magid DJ, Chalkidou K.

J Clin Epidemiol. 2009 May;62(5):464-75. doi: 10.1016/j.jclinepi.2008.12.011.

PMID:
19348971
3.

Pragmatic vs. explanatory: an adaptation of the PRECIS tool helps to judge the applicability of systematic reviews for daily practice.

Koppenaal T, Linmans J, Knottnerus JA, Spigt M.

J Clin Epidemiol. 2011 Oct;64(10):1095-101. doi: 10.1016/j.jclinepi.2010.11.020. Epub 2011 Apr 6.

PMID:
21474282
4.

The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study.

Bratton DJ, Nunn AJ, Wojnarowska F, Kirtschig G, Sandell A, Williams HC.

Trials. 2012 Apr 27;13:50. doi: 10.1186/1745-6215-13-50.

5.

The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) instrument was useful for refining a randomized trial design: experiences from an investigative team.

Riddle DL, Johnson RE, Jensen MP, Keefe FJ, Kroenke K, Bair MJ, Ang DC.

J Clin Epidemiol. 2010 Nov;63(11):1271-5. doi: 10.1016/j.jclinepi.2010.03.006. Epub 2010 Jun 17.

6.

Making clinical trials more relevant: improving and validating the PRECIS tool for matching trial design decisions to trial purpose.

Loudon K, Zwarenstein M, Sullivan F, Donnan P, Treweek S.

Trials. 2013 Apr 27;14:115. doi: 10.1186/1745-6215-14-115.

7.

Do randomized controlled nursing trials have a pragmatic or explanatory attitude? Findings from the Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool exercise.

Palese A, Bevilacqua MG, Dante A; E–P Group.

J Nurs Res. 2014 Sep;22(3):216-20. doi: 10.1097/jnr.0000000000000045.

PMID:
25111115
8.

[Progress in research of pragmatic-explanatory continuum indicator summary].

Hu G, Hu Y, Zhan S.

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Mar;37(3):439-42. doi: 10.3760/cma.j.issn.0254-6450.2016.03.031. Chinese.

PMID:
27005554
9.

Use of PRECIS ratings in the National Institutes of Health (NIH) Health Care Systems Research Collaboratory.

Johnson KE, Neta G, Dember LM, Coronado GD, Suls J, Chambers DA, Rundell S, Smith DH, Liu B, Taplin S, Stoney CM, Farrell MM, Glasgow RE.

Trials. 2016 Jan 16;17:32. doi: 10.1186/s13063-016-1158-y.

10.
11.

How pragmatic or explanatory is the randomized, controlled trial? The application and enhancement of the PRECIS tool to the evaluation of a smoking cessation trial.

Selby P, Brosky G, Oh PI, Raymond V, Ranger S.

BMC Med Res Methodol. 2012 Jul 23;12:101. doi: 10.1186/1471-2288-12-101.

12.

Alternative approaches to tuberculosis treatment evaluation: the role of pragmatic trials.

Bratton DJ, Nunn AJ.

Int J Tuberc Lung Dis. 2011 Apr;15(4):440-6. doi: 10.5588/ijtld.10.0732.

PMID:
21396200
13.
14.

The PRECIS-2 tool has good interrater reliability and modest discriminant validity.

Loudon K, Zwarenstein M, Sullivan FM, Donnan PT, Gágyor I, Hobbelen HJSM, Althabe F, Krishnan JA, Treweek S.

J Clin Epidemiol. 2017 Jun 8. pii: S0895-4356(16)30601-1. doi: 10.1016/j.jclinepi.2017.06.001. [Epub ahead of print]

PMID:
28603007
15.

Applying the PRECIS criteria to describe three effectiveness trials of weight loss in obese patients with comorbid conditions.

Glasgow RE, Gaglio B, Bennett G, Jerome GJ, Yeh HC, Sarwer DB, Appel L, Colditz G, Wadden TA, Wells B.

Health Serv Res. 2012 Jun;47(3 Pt 1):1051-67. doi: 10.1111/j.1475-6773.2011.01347.x. Epub 2011 Nov 2.

16.

CHARTing a Path to Pragmatic Tobacco Treatment Research.

Cruvinel E, Richter KP, Stoney C, Duffy S, Fellows J, Harrington KF, Rigotti NA, Sherman S, Tindle HA, Shireman TI, Shelley D, Waiwaiole L, Cummins S.

Am J Prev Med. 2016 Oct;51(4):630-6. doi: 10.1016/j.amepre.2016.05.025.

PMID:
27647063
17.

Explanatory versus pragmatic trial-based economic evaluations: application to alternative therapies for burns.

Carayanni V, Tsati E.

Expert Rev Pharmacoecon Outcomes Res. 2010 Feb;10(1):37-48. doi: 10.1586/erp.09.75. Review.

PMID:
20121563
18.

How pragmatic is it? Lessons learned using PRECIS and RE-AIM for determining pragmatic characteristics of research.

Gaglio B, Phillips SM, Heurtin-Roberts S, Sanchez MA, Glasgow RE.

Implement Sci. 2014 Aug 28;9:96. doi: 10.1186/s13012-014-0096-x.

19.

Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?

Mansouri A, Cooper B, Shin SM, Kondziolka D.

J Neurosurg. 2016 Feb;124(2):558-68. doi: 10.3171/2014.12.JNS142465. Epub 2015 Aug 28. Review.

PMID:
26315006
20.

Applying the Pragmatic-Explanatory Continuum Indicator Summary Model in a Primary Care-Based Lifestyle Intervention Trial.

Rosas LG, Lv N, Azar K, Xiao L, Yank V, Ma J.

Am J Prev Med. 2015 Sep;49(3 Suppl 2):S208-14. doi: 10.1016/j.amepre.2015.05.011.

Supplemental Content

Support Center